Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ali Hafezi-Moghadam, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Ali Hafezi-Moghadam and Evangelos Gragoudas.
Connection Strength

0.782
  1. VLA-4 blockade suppresses endotoxin-induced uveitis: in vivo evidence for functional integrin up-regulation. FASEB J. 2007 Feb; 21(2):464-74.
    View in: PubMed
    Score: 0.346
  2. Vascular adhesion protein-1 blockade suppresses choroidal neovascularization. FASEB J. 2008 Aug; 22(8):2928-35.
    View in: PubMed
    Score: 0.095
  3. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci. 2008 Feb; 49(2):726-31.
    View in: PubMed
    Score: 0.093
  4. In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis. FASEB J. 2008 Jun; 22(6):1973-80.
    View in: PubMed
    Score: 0.093
  5. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis. FASEB J. 2008 Apr; 22(4):1094-103.
    View in: PubMed
    Score: 0.092
  6. Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2007 May; 48(5):2268-77.
    View in: PubMed
    Score: 0.022
  7. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2006 Jun; 47(6):2623-31.
    View in: PubMed
    Score: 0.021
  8. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci. 2006 Jan; 47(1):357-63.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.